PAS
PYXS icon

Point72 Asia (Singapore)’s Pyxis Oncology PYXS Stock Holding History

Point72 Asia (Singapore)’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$40.1K Sell
18,057
-1,171
-6% -$1.69K 0.01% 601
2025
Q2 		$21.2K Buy
+19,228
New +$21.7K ﹤0.01% 725
2024
Q2 		– Sell
-29,835
Closed -$127K – 1415
2024
Q1 		$127K Buy
+29,835
New +$125K 0.03% 572

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Point72 Asia (Singapore)'s PYXS Position: Q3 2025 in Review

Point72 Asia (Singapore) reduced its Pyxis Oncology (PYXS) stake by 6.1% in Q3 2025, selling an estimated $1.69K and leaving 18,057 shares worth $40.1K. The position accounts for 0.01% of the portfolio, ranked #601.

Point72 Asia (Singapore) first reported a position in PYXS in Q1 2024 and has held it in 3 quarters since. The position peaked at $127K in Q1 2024. 73 funds tracked by Wall St. Rank hold PYXS as of Q3 2025.

  • Point72 Asia (Singapore) held 18,057 shares of Pyxis Oncology worth $40.1K as of Q3 2025.
  • Point72 Asia (Singapore) sold 1,171 Pyxis Oncology shares in Q3 2025, an estimated $1.69K.
  • Pyxis Oncology made up 0.01% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #601 holding.
  • Point72 Asia (Singapore) first reported a position in Pyxis Oncology in Q1 2024 and has held it in 3 quarters since.
  • Point72 Asia (Singapore)'s Pyxis Oncology position peaked at $127K in Q1 2024.
  • 73 funds tracked by Wall St. Rank held Pyxis Oncology as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.